Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05346692 · ClinicalTrials.gov registry record · Early Phase 1
Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer
A Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, sponsored by Emory University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 73
- Enrollment target
- 1
- Study location
NCT05346692: Completed Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, sponsored by Emory University.
NCT05346692 is a Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm that has completed, run by Emory University. The registered enrollment target is 73 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05346692, a Early Phase 1 study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase I trial tests a digital meditation for postoperative pain control after abdominal surgery for cancer. Mindfulness interventions such as guided meditation may improve pain control and decrease stress. Including a brief mindfulness intervention administered via test messages as part of postoperative care may improve pain severity, decrease opioid use, and improve patient responses to non-surgical treatments.
Primary Outcome
Adverse events (AEs) will be reported, and summarized using frequencies and percentages. An AE will be considered unexpected if the nature, severity, or frequency of the event is not consistent with the risk information previously described for the study intervention. Unexpected AEs will be summarized descriptively. The most common adverse events reported within the mindfulness literature anxiety, depression, and cognitive anomalies. The overall prevalence of meditation adverse events is 8%, whi
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Interview
- OTHER Text Message-Based Navigation Intervention
Study Locations (1)
Georgia
- Emory University/Winship Cancer Institute - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2023-07-12 |
| Phase | Early Phase 1 |
What the finished NCT05346692 record still lists
NCT05346692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT05346692 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05346692 about?
NCT05346692 is a clinical study titled "Digital Meditation for Postoperative Pain Control After Abdominal Surgery for Cancer". This phase I trial tests a digital meditation for postoperative pain control after abdominal surgery for cancer. Mindfulness interventions such as guided meditation may improve pain control and decrease stress. Including a brief mindfulness intervention administered via test messages as part of post...
What is the current status of trial NCT05346692?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 73 participants. The study started on 2022-03-28. Estimated completion is 2023-07-12.
What conditions does trial NCT05346692 study?
This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm.
What interventions are being tested in trial NCT05346692?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Text Message-Based Navigation Intervention (OTHER).
Who is sponsoring clinical trial NCT05346692?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05346692 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05346692's enrollment target sits among peer trials
73 106th of 176 higher than 71 of 176 other Malignant Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
RECRUITING · Early Phase 1
-
Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural Effusion
RECRUITING · Early Phase 1
-
Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
RECRUITING
-
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI